SOPHiA GENETICS SA Ordinary Shares (SOPH) is a publicly traded Healthcare sector company. As of May 20, 2026, SOPH trades at $4.79 with a market cap of $336.70M and a P/E ratio of 0.00. SOPH moved +3.42% today. Year to date, SOPH is +5.87%; over the trailing twelve months it is +69.10%. Its 52-week range spans $2.58 to $5.70. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces SOPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SOPHiA GENETICS SA Ordinary Shares (SOPH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SOPH moved +3.42% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.79 |
| Market Cap | $336.70M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.70 |
| 52-Week Low | $2.58 |
| Volume | 56.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover SOPH: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.50.